Adarza Biosystems Closes On $17 Million Series C Financing

Adarza, a Serra Capital II portfolio company, has closed $17M in Series C Financing. The company which is leading next generation innovator in label-free, multiplex assays, announced the financing on January 17.

Proceeds from the financing will be used to further expand production capacity in its St. Peters, Mo. manufacturing facility and fund final development and commercialization of Adarza’s first immunoassay product consumable and instrument platform.